Development of a Fluorescence Polarization Assay for the SARS-CoV-2 Papain-like Protease
ACS Pharmacology & Translational Science · 14.03.2025 · 8 (3) · 774-784
DOI: 10.1021/acsptsci.4c00642 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 26.02.2025. Verfasst von Kan Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, New Jersey 08854, United…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, New Jersey 08854, United States.
ORCID-Profile: Jun Wang
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Li, K., Jadhav, P., Wen, Y., Tan, H., & Wang, J. (2025). Development of a Fluorescence Polarization Assay for the SARS-CoV-2 Papain-like Protease. ACS Pharmacology & Translational Science, 8(3), 774-784. https://doi.org/10.1021/acsptsci.4c00642
Vancouver
Li K, Jadhav P, Wen Y, Tan H, Wang J. Development of a Fluorescence Polarization Assay for the SARS-CoV-2 Papain-like Protease. ACS Pharmacology & Translational Science. 2025;8(3):774-784. doi:10.1021/acsptsci.4c00642
BibTeX
@article{Li2025,
author = {Li, Kan and Jadhav, Prakash and Wen, Yu and Tan, Haozhou and Wang, Jun},
title = {Development of a Fluorescence Polarization Assay for the SARS-CoV-2 Papain-like Protease},
journal = {ACS Pharmacology & Translational Science},
year = {2025},
volume = {8},
number = {3},
pages = {774--784},
doi = {10.1021/acsptsci.4c00642}
}
EUVIMED